Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 28, 2022 17:29 ET | Source: SPK Acquisition Corp.

Varian Biopharmaceuticals, Inc. and SPK Acquisition Corp. Announce Release of Investor Presentation Regarding Previously Announced Merger; Provide Corporate Update

NAPLES, Fla., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Varian Biopharmaceuticals, Inc. (“Varian Bio”), a private, precision oncology company developing novel therapeutics for the treatment of cancer, and...
February 14, 2022 09:00 ET | Source: SPK Acquisition Corp.

Varian Biopharmaceuticals, Inc., a Precision Oncology Company, to Become Publicly Traded Through a Merger with SPK Acquisition Corp.

Varian Biopharmaceutical is developing a proprietary atypical protein kinase C iota inhibitor in multiple formulations for a broad range of tumor typesCombined company expected to have a...
July 23, 2021 06:00 ET | Source: SPK Acquisition Corp.

SPK Acquisition Corp. Announces that Common Stock and Rights to Commence Separate Trading on or about July 23, 2021

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- SPK Acquisition Corp. ("the Company" or "SPK") (NASDAQ: SPKAU), a blank check company formed for the purpose of entering into a merger, share exchange,...
June 07, 2021 21:55 ET | Source: SPK Acquisition Corp.

SPK Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering

NEW YORK, June 07, 2021 (GLOBE NEWSWIRE) -- SPK Acquisition Corp. (NASDAQ: SPKAU, the "Company") announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The...